62.84
U S Physical Therapy Inc stock is traded at $62.84, with a volume of 252.67K.
It is down -5.35% in the last 24 hours and up +0.05% over the past month.
US Physical Therapy Inc through its subsidiaries operate outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
See More
Previous Close:
$66.39
Open:
$65.97
24h Volume:
252.67K
Relative Volume:
1.26
Market Cap:
$956.35M
Revenue:
$795.49M
Net Income/Loss:
$62.33M
P/E Ratio:
126.51
EPS:
0.4967
Net Cash Flow:
$67.97M
1W Performance:
+0.02%
1M Performance:
+0.05%
6M Performance:
-20.17%
1Y Performance:
-15.59%
U S Physical Therapy Inc Stock (USPH) Company Profile
Name
U S Physical Therapy Inc
Sector
Industry
Phone
(713) 297-7000
Address
1300 WEST SAM HOUSTON PARKWAY SOUTH, HOUSTON, TX
Compare USPH vs HCA, THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
USPH
U S Physical Therapy Inc
|
62.84 | 997.14M | 795.49M | 62.33M | 67.97M | 0.4967 |
|
HCA
Hca Healthcare Inc
|
388.16 | 86.51B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
178.50 | 15.43B | 21.46B | 2.65B | 3.35B | 19.23 |
|
DVA
Davita Inc
|
210.58 | 13.46B | 13.84B | 1.10B | 1.49B | 10.42 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.57 | 12.60B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
EHC
Encompass Health Corp
|
97.89 | 9.86B | 6.07B | 793.80M | 464.40M | 5.9914 |
U S Physical Therapy Inc Stock (USPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-26 | Resumed | Jefferies | Buy |
| Sep-18-25 | Resumed | JP Morgan | Overweight |
| Dec-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-16-24 | Initiated | JMP Securities | Mkt Outperform |
| Oct-07-24 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-22-23 | Initiated | JP Morgan | Overweight |
| Jun-30-23 | Initiated | BofA Securities | Buy |
| Dec-14-21 | Upgrade | CJS Securities | Market Perform → Market Outperform |
| Aug-06-21 | Reiterated | Barrington Research | Outperform |
| May-07-21 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-03-21 | Upgrade | Jefferies | Hold → Buy |
| Feb-26-21 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-08-20 | Reiterated | Barrington Research | Outperform |
| Apr-30-20 | Downgrade | Sidoti | Buy → Neutral |
| Mar-11-20 | Upgrade | Sidoti | Neutral → Buy |
| Feb-28-20 | Reiterated | Barrington Research | Outperform |
| Nov-08-19 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Mar-08-19 | Initiated | William Blair | Outperform |
| Nov-03-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-08-17 | Upgrade | Sidoti | Neutral → Buy |
| Jul-03-17 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Mar-17-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Nov-04-16 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Aug-05-16 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| May-06-16 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Mar-01-16 | Downgrade | Jefferies | Buy → Hold |
| Nov-06-15 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| May-06-15 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Dec-12-13 | Reiterated | Dougherty & Company | Buy |
| Aug-23-13 | Reiterated | Dougherty & Company | Buy |
| Jan-14-13 | Reiterated | Dougherty & Company | Buy |
| Jul-09-10 | Initiated | JMP Securities | Mkt Outperform |
View All
U S Physical Therapy Inc Stock (USPH) Latest News
From clinic mainstay to investor talking point, USPH’s outpatient physical therapy sets its pace - AD HOC NEWS
USPH Q1 2026 Earnings: EPS Misses Estimates by 17.25%, Stock Edge LowerPeak Earnings Alert - newsline.com
NewtekOne Fixed-Rate Notes (NEWTI) Hold Steady at $25.19 Amid Stable TradingInsider Buying Alerts - newsline.com
U.S. Physical Therapy Stock (US9175021020): Insider buying as shares trade near 52-week low - AD HOC NEWS
Hodges Capital Management Inc. Acquires Shares of 35,105 U.S. Physical Therapy, Inc. $USPH - MarketBeat
Insider Buying: Peter Minan Acquires Shares of US Physical Thera - GuruFocus
U.S. Physical Therapy (USPH) Gains 1.67% as It Bounces Off Support; Key Resistance in SightSynthetic Short - newsline.com
Insider Buying: U.S. Physical Therapy (NYSE:USPH) Director Acquires 288 Shares of Stock - MarketBeat
U.S. physical therapy director Peter Minan acquires $48,776 in stock By Investing.com - Investing.com India
Peter Francis Minan Acquires 492 Shares of U.S. Physical Therapy (NYSE:USPH) Stock - MarketBeat
U.S. physical therapy director Peter Minan acquires $48,776 in stock - Investing.com
US Physical Therapy (USPH) director adds 780 shares in open-market buys - Stock Titan
Technical Reactions to USPH Trends in Macro Strategies - Stock Traders Daily
USPH Technical Analysis & Stock Price Forecast - Intellectia AI
USPH Q1 2026 Earnings: EPS Misses Estimates Despite Positive Stock MovementPost-Earnings Drift - newsline.com
USPH Q1 2026 Earnings: EPS Misses Estimates by 17.25%, Stock Rises 2.72%Return On Capital - newsline.com
Stock List: Research Stocks from Around the World - GuruFocus
USPH Slips 1.25% as Support Levels Loom: U.S. Physical Therapy (USPH) in FocusThematic ETF Flow - newsline.com
How The Story Is Shifting For U.S. Physical Therapy (USPH) As Price Targets Reset - Yahoo Finance
USPH Q1 2026 Earnings: EPS Misses Estimates by 17.25%, Stock DeclinesCash Flow Report - newsline.com
U.S. Physical Therapy (USPH) director receives 2,306-share restricted stock grant - Stock Titan
Director at U.S. Physical Therapy (NYSE: USPH) receives 2,306 restricted shares - Stock Titan
US Physical Therapy (NYSE: USPH) director receives 2,306 restricted stock shares - Stock Titan
Director at U S Physical Therapy (NYSE: USPH) granted 2,306 shares - Stock Titan
U.S. Physical Therapy (NYSE: USPH) director receives 2,306-share stock grant - Stock Titan
USPH Q1 2026 Earnings: EPS Misses Estimates by 17.25%, Stock Rises 3.3%Non-GAAP Earnings - The Legal Advocate
USPH Q1 2026 Earnings: EPS Misses Estimates by 17.25% but Stock Gains 3.32%Investor Earnings Call - The Legal Advocate
Trading the Move, Not the Narrative: (USPH) Edition - Stock Traders Daily
U.S. Physical Therapy (USPH) Edges Higher Near Resistance as Sector Trends Remain SupportiveDescending Triangle - The Legal Advocate
U.S. Physical Therapy (USPH) Holds Steady Near $62 as Support Levels TestedPCR Extreme - The Legal Advocate
USPH Q1 2026 Earnings: Earnings Miss Expectations as EPS Falls Short by 17.25%Return On Capital - newsline.com
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
USPH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
USPH Q1 2026 Earnings: EPS Misses Estimates by Over 17%, Stock DeclinesNet Profit Margin - The Legal Advocate
U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade) (NYSE:USPH) - Seeking Alpha
USPH Q1 2026 Earnings: EPS Miss Weighs on Investor Sentiment Despite Operational ConsistencyEBITDA Estimate Trend - newsline.com
U.S. Physical Therapy Stock Stagnates at $65.04, Underperforms S&P 500News and Statistics - IndexBox
3 Reasons USPH is Risky and 1 Stock to Buy Instead - Yahoo Finance
Director at U S Physical Therapy (NYSE: USPH) receives stock grant - Stock Titan
U.S. Physical Therapy shareholders approve all proposals at annual meeting - Investing.com India
U.S. Physical Therapy shareholders approve all proposals at annual meeting By Investing.com - Investing.com India
U.S. Physical Therapy (USPH) director granted 2,306 restricted shares at $61.61 - Stock Titan
[Form 4] U S PHYSICAL THERAPY INC /NV Insider Trading Activity - Stock Titan
US Physical Therapy (USPH) awards 2,306 restricted shares to director Harris - Stock Titan
U.S. Physical Therapy (USPH) director granted 2,306 restricted shares as equity pay - Stock Titan
US Physical Therapy Shareholders Back Board, Pay, Auditor - The Globe and Mail
USPH (USPH) director Peter Minan discloses initial 125-share stake - Stock Titan
[8-K] U S PHYSICAL THERAPY INC /NV Reports Material Event - Stock Titan
U.S. Physical Therapy, Inc. Approves Election of Peter F. Minan as Director - marketscreener.com
US Physical Therapy (USPH) Q1 earnings and revenues lag estimates - MSN
Why It Might Not Make Sense To Buy U.S. Physical Therapy, Inc. (NYSE:USPH) For Its Upcoming Dividend - simplywall.st
U S Physical Therapy Inc Stock (USPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):